SCHEMBL21393088

SCHEMBL21393088

CC(CCNC(=O)c1ccccc1)c1nc2ccccc2s1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LOXL2 Q9Y4K0 1/20 0.52
▸ CSNK1D P48730 1/20 0.52
▸ RAB9A P51151 5/20 0.50
▸ NPC1 O15118 4/20 0.50
▸ KMT2A Q03164 3/20 0.50
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ HTT P42858 1/20 0.49
▸ ALDH1A1 P00352 1/20 0.48
▸ EPHX2 P34913 1/20 0.48
▸ SCD O00767 1/20 0.46
▸ ALOX5 P09917 1/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ CASP1 P29466 1/20 0.46
▸ GAA P10253 2/20 0.45
▸ HPGD P15428 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ ESR1 P03372 1/20 0.45
▸ POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5256102 0.79 LOXL2 (0.60) LOXL2RAB9ANPC1KMT2ASMN1; SMN2
SCHEMBL15149247 0.76 LOXL2 (0.63) LOXL2CSNK1DRAB9ANPC1KMT2A
SCHEMBL10722901 0.74 EPHX2 (0.73) RAB9ANPC1KMT2ASMN1; SMN2MEN1
SCHEMBL20178515 0.74 LOXL2 (0.69) LOXL2RAB9ANPC1SMN1; SMN2ALOX5
SCHEMBL7723002 0.72 HTT (0.67) CSNK1DRAB9ANPC1KMT2ASMN1; SMN2
SCHEMBL496789 0.72 SMN1; SMN2 (0.81) RAB9ANPC1SMN1; SMN2HTTEPHX2
SCHEMBL22919771 0.72 LOXL2 (0.65) LOXL2RAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL3963337 0.71 HPGD (0.60) LOXL2CSNK1DRAB9ANPC1KMT2A
SCHEMBL21013873 0.71 LOXL2 (0.73) LOXL2RAB9AALDH1A1ALOX5ALOX15
SCHEMBL1412715 0.71 LOXL2 (0.73) LOXL2RAB9AALDH1A1ALOX5ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11666661-B2 Methods and compounds for targeted autophagy THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-06-06 — — US disclosed
US-20190290778-A1 METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY FRONTIER MEDICINES CORPORATION 2019-09-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190290778-A1 METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY ATG7, BECN1, SQSTM1 LOXL2 1786/4885CSNK1D 3887/4885RAB9A 223/4885
US-11666661-B2 Methods and compounds for targeted autophagy ATG7, BECN1, SQSTM1 LOXL2 1786/4885CSNK1D 3887/4885RAB9A 223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback